Comprehensive Epilepsy Center
Schedule appointment- American Medical Association
- American Parkinson Disease Association
- American Cancer Society
- American Diabetes Association
- American Heart Association
- Brain Injury Association of America
- ALS Association
- ALS Therapy Development Institute
- ALS Pathways
- ALS Therapy Alliance
- National Amyotrophic Lateral Sclerosis (ALS) Registry
- ALS Clinical Trials at the U.S. National Institutes of Health
- I Am ALS
- Northeast Amyotrophic Lateral Sclerosis Consortium
- Quackwatch
- National Organization for Rare Disorders
- Gregg Pearson Foundation
- The Assistance Fund
- Healthwell Foundation
- Dystonia Medical Research Foundation
- Medicare
- The Foundation for Peripheral Neuropathy
- GBS - CIDP Foundation International
- The National Headache Foundation
- Healing Hands Ministries Behavioral Health Center
- Josh Provides Epilepsy Assistance Foundation
- Metrocare Adult Mental Health Services
- Metrocare Mobile Crisis Outreach Team
- Alzheimers Foundation of America
- Alzheimer's Association of Greater Dallas
- Dallas Area Agency on Aging
- Family Caregiver Alliance
- Dementia Society of America
- Dementia Action Alliance
- Jewish Family Services
- The Senior Source
- Multiple Sclerosis Association of America
- MS Focus
- Above MS
- Can Do Multiple Sclerosis
- International Organization of Multiple Sclerosis Nurses
- MS International Foundation
- National Multiple Sclerosis Society
- The Consortium of Multiple Sclerosis Centers (CMSC)
- International Parkinson and Movement Disorder Society
- National Center for Complementary and Integrative Health
- National Institute for Neurological Disorders and Stroke
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- American Migraine Foundation
- BOTOX® for Chronic Migraine
- MyChronicMigraine
- The National Headache Foundation
- American Migraine Foundation
- BOTOX® for Chronic Migraine
- American Migraine Foundation
- MyChronicMigraine
- Beeman Hotel Book Your Stay
- ClinicalTrials.gov
- National Institutes of Health
- ClinicalTrials.gov
- VYEPTI® (eptinezumab-jjmr)
- TYSABRI® (natalizumab)
- GAMUNEX®-C
- GAMMAGARD LIQUID
- OCREVUS® (ocrelizumab)
- SOLIRIS® (eculizumab)
- VYVGART® (efgartigimod alfa-fcab)
- RITUXAN® (rituximab)
- FabrazymeE® (agalsidase beta)
- INFLECTRA® (infliximab-dyyb)
- ONPATTRO® (patisiran)
- LEMTRADA® (alemtuzumab)
- LEQEMBI® (lecanemab-irmb)
- TEPEZZA® (teprotumumab-trbw)
- BRIUMVI® (ublituximab-xiiy)
- ULTOMIRIS® (ravulizumab-cwvz)
- Prolia® (denosumab)
Menu